• Article

Cost-Efectiveness of Delayed-Release Dimethyl Fumarate Compared to Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remiting Multiple Sclerosis

Citation

Mauskopf, J., Fay, M., Iyer, R., & Livingston, T. (2014). Cost-Efectiveness of Delayed-Release Dimethyl Fumarate Compared to Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remiting Multiple Sclerosis. Value in Health, 17(3), A60-A61.